-
News Source: Uinta County News
| 4 months ago
It turns them into serial killers.' Professor Peter Johnson, Cancer Research UK's chief clinician, said: 'These exciting preliminary results come from using them to harness the body's own immune response in a new way. 'Although the side effects need...
-
News Source: Uinta County News
| 4 months ago
BST 14/08/2008 Earlier this year doctors announced that a patient with advanced skin cancer was free of the disease two years after they injected him with billions of his own immune cells using a different method. However, experts warned at the time...
-
News Source: Epoch Times
| 4 months ago
A new kind of antibody drug that makes the body's own "killer" cells fight tumours has produced promising early-stage results in patients with a deadly form of blood cancer, researchers said on Thursday. All seven patients with previously incurable...
-
News Source: The Globe & Mail
| 4 months ago
Precisely targeted radiation therapy can eradicate tumors that have spread to other parts of the body, offering more months or years of life to patients who have no other options, U.S. researchers report. They said new radiation techniques can attack...
-
News Source: Androscoggin News
| 4 months ago
Typically antibodies cannot engage T cells because T cells lack the appropriate receptors for binding antibodies. Previous attempts have shown the potential of T cells to treat cancer, but the therapeutic approaches tested to date have been hampered...
-
News Source: Androscoggin News
| 4 months ago
II study of ASA404 in hormone-refractory prostate cancer, in which patients were randomised to receive either 1200 mg/m2 ASA404 plus the chemotherapy drug docetaxel or a control treatment of docetaxel alone. The hazard ratio expressing the relative...
-
News Source: Uinta County News
| 4 months ago
Pervasis COO Stephen Bollinger is gellin' with the company's new cell transplantation product, designed to prevent rejection of therapeutic cells. Friday, August 15, 2008 Pervasis goes old school with cell-transplant tech With so much attention —...
-
News Source: NewKerala
| 4 months ago
T he researchers say that they have found out how to get a higher proportion of a given dose of medications into tumour cells, to avoid "spillovers" that can kill the healthy cells. They believe that their method can reduce the amount of medication...
-
News Source: Androscoggin News
| 4 months ago
Publishing online in the Journal Science, researchers compared patients with colon cancer to those without the disease. They found a gene mutation was present in ten to twenty percent of patients, but was found in less thatn three percent of healthy...